Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Peiper

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal of Virology|August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infectionT Murakami, T Y Zhang, Y Koyanagi, et al.
Journal of Virology|September 1, 1997
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1B J Doranz, Z H Lu, J Rucker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strainsA L Edinger, A Amedee, K Miller, et al.
Nature|June 20, 1996
Identification of a major co-receptor for primary isolates of HIV-1H Deng, R Liu, W Ellmeier, et al.
Oncogene|February 14, 2017
Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signalingZ-M Shi, L Wang, H Shen, et al.
Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal of Virology|August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infectionT Murakami, T Y Zhang, Y Koyanagi, et al.
Journal of Virology|September 1, 1997
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1B J Doranz, Z H Lu, J Rucker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strainsA L Edinger, A Amedee, K Miller, et al.
Nature|June 20, 1996
Identification of a major co-receptor for primary isolates of HIV-1H Deng, R Liu, W Ellmeier, et al.
Oncogene|February 14, 2017
Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signalingZ-M Shi, L Wang, H Shen, et al.
Journal of Virology|April 1, 1997
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutationS Rana, G Besson, D G Cook, et al.
Pageof 10